Glaucoma, which is characterized by the increase of intraocular pressure, is the second main cause of blindness worldwide. However, an efficient and 100% definitive treatment still does not exist. This cause for concern as 70 million people in the world are affected and the numbers keep growing due to population aging. So, EyeOP1, a noninvasive treatment device for glaucoma engineered by EyeTechCare, a small business created in 2008 by three experienced managers with complementary medical, industrial and regulatory skills and expertise, seems to be a very promising solution. This breakthrough innovation, which should be on the market in late 2010 or early 2011, has just received the first prize at the 2010 Innovative Technologies Competition. Organized by Alliance pour le Génie Biologique et Médical (AGBM), the prize is given to small businesses whose projects have a potential for major advances in medical care.
The new noninvasive method is based on the use of HIFU (High Intensity Focused Ultrasound), a technology that clears the way for accurate, fast, efficient, well-tolerated and non-operator dependent outpatient treatment that will lower costs and patient risk. An international multicenter study should be rolled out from 2011 to 2013 to collect clinical data on a high number of patients and to provide enough perspective. "The technology engineered by EyeTechCare appealed to us because it brings the hope of a solution to a world public health problem," said Prize Jury President Mathias Fink, a member of the French Academy of Science and the Collège de France.